<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[pharmaceutical company and rhodia Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/pharmaceutical+company+and+rhodia.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to pharmaceutical company and rhodia]]></description>
	<s:counts start="0" returned="9" found="9" />
	<language>en-us</language>
	<item>
		<title><![CDATA[European specialty players revamp and replace their strategy. (Focus 2003: Specialty Chemicals/ChemSpec Europe Preview).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200304/ai_n13360184]]></link>
		<description><![CDATA[Threatened with commoditization, companies take drastic measures,  not only cutting costs and divesting operations, but also seeking an  entirely different, closer relationship with their customers.       Under pressure from sluggish demand, difficult    Threatened with commoditization, companies take drastic measures, ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Apr 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/chemical+company.html"><![CDATA[chemical company]]></category>
		<category domain="http://resources.bnet.com/topic/chemicals.html"><![CDATA[chemicals]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[company]]></category>
		<category domain="http://resources.bnet.com/topic/life+science.html"><![CDATA[life science]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rhodia.html"><![CDATA[Rhodia]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[sales]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Chirality a Hot Commodity For Fine Chemical Players.(chiral molecules, single enantiomer drugs)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200012/ai_n13186882]]></link>
		<description><![CDATA[Rhodia Chirex, Dow and Cambrex beef up the toolbox.       SEVERAL CONTRACT manufacturing companies are stepping up their  ability to serve a potentially lucrative market area: the development,  manufacture and supply of novel chiral molecules. Compani    Rhodia Chirex, Dow and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 18 Dec 2000 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/molecule.html"><![CDATA[molecule]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rhodia.html"><![CDATA[Rhodia]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/the+dow+chemical+co..html"><![CDATA[The Dow Chemical Co.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DOW</category>
		<category domain="tickers">DOW</category>
	</item>
	<item>
		<title><![CDATA[Rhodia's Deal For ChiRex Draws Skepticism.(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200007/ai_n13311661]]></link>
		<description><![CDATA[Analysts caution that obstacles may be greater than the companies  expect.       RHODIA'S BID to take over ChiRex, the US-based pharmaceutical  contract research and manufacturing company, underscores the specialty  chemicals manufacturer's determinat    Analysts caution that obstacles may be greater...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 31 Jul 2000 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rhodia.html"><![CDATA[Rhodia]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Rhodia Strategically Positions Its Pharma Ingredients Business.(Brief Article)(Statistical Data Included)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200004/ai_n13237426]]></link>
		<description><![CDATA[Rhodia is repositioning its pharmaceutical ingredients business as  part of its strategy to expand its leading position in key markets. A  major part of that strategy is to reinforce its status as a  high-security, low-risk global supplier of pharmace    Rhodia is repositioning its pharmaceutical...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 03 Apr 2000 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rhodia.html"><![CDATA[Rhodia]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Rhodia to Invest in Contract Manufacturing.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200003/ai_n13237541]]></link>
		<description><![CDATA[RHODIA PLANS to invest [epsilon]30 million ($30 million) this year  in facilities for pharmaceutical contract manufacturing to help it meet  its target of a four-fold increase in custom synthesis sales, to  [epsilon]120 million, by 2004.       The inv    RHODIA...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 27 Mar 2000 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rhodia.html"><![CDATA[Rhodia]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Rhodia Targets GMP Manufacturing.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_199908/ai_n13228944]]></link>
		<description><![CDATA[RHODIA IS PLANNING a fivefold increase in its sales of  pharmaceutical intermediates made to current Good Manufacturing Practice  GMP standards during the next five years.       Last year, the company acquired its first cGMP plant, a facility in  Ho   ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 09 Aug 1999 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rhodia.html"><![CDATA[Rhodia]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Rhodia Acquires GMP Unit in UK From RPR.(Rhone-Poulenc Rorer )(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_199812/ai_n13223456]]></link>
		<description><![CDATA[RHODIA IS EXPANDING its contract manufacturing activities in  pharmaceutical intermediates by acquiring its first multipurpose plant  that has received Food and Drug Administration approval for current Good  Manufacturing Practice cGMP.       The co    RHODIA IS EXPANDING its contract manufacturing...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 21 Dec 1998 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rhodia.html"><![CDATA[Rhodia]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Bulk analgesics moving to handful of big players.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_199801/ai_n13186267]]></link>
		<description><![CDATA[BASF buyout of Celanese in BHC is latest consolidation move.       THE US BULK analgesics market is consolidating, and there could be  more moves to come. BASF Corporation's acquisition of 100 percent  control of ibuprofen venture BHC last month was t  ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 12 Jan 1998 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/basf+ag.html"><![CDATA[BASF AG]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[company]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rhodia.html"><![CDATA[Rhodia]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BASF Y</category>
		<category domain="tickers">BASF Y</category>
	</item>
	<item>
		<title><![CDATA[Bulk Analgesics Moving To Handful of Big Players]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_199801/ai_n13242597]]></link>
		<description><![CDATA[BASF buyout of Celanese in BHC is latest consolidation move.     THE US BULK analgesics market is consolidating, and there could be  more moves to come. BASF Corporation's acquisition of 100 percent  control of ibuprofen venture BHC last month was the l  BASF buyout...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 12 Jan 1998 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/basf+ag.html"><![CDATA[BASF AG]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[company]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rhodia.html"><![CDATA[Rhodia]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BASF Y</category>
		<category domain="tickers">BASF Y</category>
	</item>
</channel>
</rss>
